Mitoguazone
From Wikipedia, the free encyclopedia
 |
|
|---|---|
 |
|
| Systematic (IUPAC) name | |
| (2E,2'E)-2,2'-(1E,2E)-propane-1,2-diylidenedihydrazinecarboximidamide | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 459-86-9 |
| ATC code | L01XX16 |
| PubChem | CID 5351154 |
| UNII | OD5Q0L447W  |
| KEGG | D07258 |
| Synonyms | 2-[[(1E)-1-(Diaminomethylidenehydrazinylidene)propan-2-ylidene]amino]guanidine |
| Chemical data | |
| Formula | C5H12N8 |
| Mol. mass | 184.20 g/mol |
 (what is this?) (verify) |
|
Mitoguazone (also known as methylglyoxal bis(guanylhydrazone) or MGBG) is a drug used in chemotherapy.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
This article about an alkene is a stub. You can help Wikipedia by expanding it. |
 |
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
